Dominik Heer

1.2k total citations
15 papers, 791 citations indexed

About

Dominik Heer is a scholar working on Molecular Biology, Pharmacology and Biomedical Engineering. According to data from OpenAlex, Dominik Heer has authored 15 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Biomedical Engineering. Recurrent topics in Dominik Heer's work include Cannabis and Cannabinoid Research (6 papers), Biofuel production and bioconversion (5 papers) and Microbial Metabolic Engineering and Bioproduction (5 papers). Dominik Heer is often cited by papers focused on Cannabis and Cannabinoid Research (6 papers), Biofuel production and bioconversion (5 papers) and Microbial Metabolic Engineering and Bioproduction (5 papers). Dominik Heer collaborates with scholars based in Switzerland, Sweden and China. Dominik Heer's co-authors include Uwe Sauer, Tobias Fuhrer, Nicola Zamboni, Daniel Heine, Bärbel Hahn‐Hägerdal, B. Mikael Bergdahl, Noriko Okudaira, Atsushi Kurihara, Takashi Izumi and Kazuya Maeda and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Applied and Environmental Microbiology.

In The Last Decade

Dominik Heer

15 papers receiving 782 citations

Peers

Countries citing papers authored by Dominik Heer

Since Specialization

Citations

This map shows the geographic impact of Dominik Heer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Heer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Heer more than expected).

Fields of papers citing papers by Dominik Heer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominik Heer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Heer. The network helps show where Dominik Heer may publish in the future.

Co-authorship network of co-authors of Dominik Heer

This figure shows the co-authorship network connecting the top 25 collaborators of Dominik Heer. A scholar is included among the top collaborators of Dominik Heer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominik Heer. Dominik Heer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Machine Learning-Assisted Iterative Screening for Efficient Detection of Drug Discovery Starting Points 2025 ·Journal of Medicinal Chemistry ·Alex T. Müller, (unknown), Dominik Heer, (unknown), (unknown), Bigna Wörsdörfer, Christian Krämer, Wolfgang Haap, (unknown), Michael Reutlinger	1
2	Exploration of (R)-[11C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Ming‐Qiang Zheng, Jiwei Gu, (unknown), (unknown), (unknown), Claudia Keller, (unknown), Ludovic Collin, Dominik Heer, Anto Pavlovic, (unknown), Matthias Wittwer, Uwe Grether, Luca Gobbi, Roger Schibli, Yiyun Huang, Linjing Mu	1
3	Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)‐[¹¹C]YH132: Application in Drug Development and Neurodegenerative Diseases 2024 ·ChemBioChem ·(unknown), (unknown), (unknown), Claudia Keller, (unknown), Dominik Heer, Ludovic Collin, Roger Schibli, Luca Gobbi, Uwe Grether, Linjing Mu	2
4	Identification of (R)-[¹⁸F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development 2023 ·Journal of Nuclear Medicine ·(unknown), Stefanie D. Krämer, Uwe Grether, Matthias Wittwer, Ludovic Collin, Bernd Kuhn, (unknown), Dominik Heer, Fionn O’Hara, Michael Honer, Anto Pavlovic, Hans Richter, Martin Ritter, (unknown), Claudia Keller, Luca Gobbi, Linjing Mu	1
5	Physiological and Molecular Characterization of Yeast Cultures Pre-Adapted for Fermentation of Lignocellulosic Hydrolysate 2023 ·Fermentation ·João Ricardo Moreira de Almeida, Magnus Wiman, Dominik Heer, Daniel P. Brink, Uwe Sauer, Bärbel Hahn‐Hägerdal, Gunnar Lidén, Marie F. Gorwa‐Grauslund	6
6	Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Uwe Grether, Jörg Benz, (unknown), Dominik Heer, (unknown), Ludovic Collin, Bernd Kuhn, Matthias Wittwer, Claudia Keller, Luca Gobbi, Roger Schibli, Linjing Mu	10
7	Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold 2022 ·Nuclear Medicine and Biology ·(unknown), Luca Gobbi, Adrienne Müller Herde, (unknown), Martin Ritter, Bernd Kuhn, Matthias Wittwer, Dominik Heer, (unknown), (unknown), Fionn O’Hara, Jörg Benz, Michael Honer, Claudia Keller, Ludovic Collin, Hans Richter, Roger Schibli, Uwe Grether, Linjing Mu	9
8	A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature 2022 ·PLoS ONE ·(unknown), (unknown), (unknown), Hans Richter, Jörg Benz, Bernd Kuhn, Dominik Heer, Matthias Wittwer, Britta Engelhardt, Uwe Grether, Ludovic Collin	4
9	6β-Hydroxycortisol Is an Endogenous Probe for Evaluation of Drug–Drug Interactions Involving a Multispecific Renal Organic Anion Transporter, OAT3/SLC22A8, in Healthy Subjects 2014 ·Drug Metabolism and Disposition ·(unknown), (unknown), Katja Damme, Dominik Heer, Yuji Kumagai, Kazuya Maeda, Nobuyuki Murayama, Noriko Okudaira, Atsushi Kurihara, Takashi Izumi, Yuichi Sugiyama, Hiroyuki Kusuhara	54
10	Dynamic metabolomics differentiates between carbon and energy starvation in recombinant Saccharomyces cerevisiae fermenting xylose 2012 ·Biotechnology for Biofuels ·B. Mikael Bergdahl, Dominik Heer, Uwe Sauer, Bärbel Hahn‐Hägerdal, (unknown)	52
11	High-Throughput, Accurate Mass Metabolome Profiling of Cellular Extracts by Flow Injection–Time-of-Flight Mass Spectrometry 2011 ·Analytical Chemistry ·Tobias Fuhrer, Dominik Heer, (unknown), Nicola Zamboni	281
12	Resistance of Saccharomyces cerevisiae to High Concentrations of Furfural Is Based on NADPH-Dependent Reduction by at Least Two Oxireductases 2009 ·Applied and Environmental Microbiology ·Dominik Heer, Daniel Heine, Uwe Sauer	133
13	Molecular basis of stress resistance in Saccharomyces cerevisiae 2009 ·Repository for Publications and Research Data (ETH Zurich) ·Dominik Heer	1
14	Identification of furfural as a key toxin in lignocellulosic hydrolysates and evolution of a tolerant yeast strain 2008 ·Microbial Biotechnology ·Dominik Heer, Uwe Sauer	213
15	Amphotericin B as a Potential Probe of the Physical State of Vesicle Membranes 2004 ·Organic Letters ·Andreas Zumbuehl, Pasquale Stano, Dominik Heer, Peter Walde, Erick M. Carreira	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact